Tag Archive for: ASCO
Coronavirus and Cancer Resources for Survivors
Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]
NCCS Presents 8th Annual Ellen L. Stovall Awards to Phuong Gallagher and Mary McCabe, RN for Their Innovation and Dedication to Cancer Survivors
FOR IMMEDIATE RELEASE
October 30, 2023
Washington, D.C. – The National Coalition for Cancer Survivorship (NCCS) presented the…
Webinar – Implementing the ASCO Guidelines for Exercise, Nutrition, and Weight Management with Your Patients and Practice
The National Coalition for Cancer Survivorship (NCCS) hosted a Survivorship Champions webinar discussing the American Society for Clinical…
NCCS Presents 7th Annual Ellen L. Stovall Award to Patricia Ganz, MD, and Alicia Staley for their Dedication to Improving Cancer Care
The National Coalition for Cancer Survivorship hosted the 7th annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer…
Health Care Roundup: NCCS COVID-19 Webinars & Podcast; Paid Leave for Vulnerable Patients; Resources for Finding Coverage; “Chemo Brain” Study; More
NCCS has been working diligently to bring you the most up-to-date and critical information for cancer survivors regarding the COVID-19 pandemic. Last week, we hosted a webinar with one of the nation’s leading oncology experts, Dr. Otis Brawley. In this webinar, he outlined how this public health crisis is impacting cancer patients and survivors and what they can do to stay safe. "This is a really difficult time. My recommendation to anyone who has cancer [...]
Health Care Roundup: White House Proposes Health Care Cuts; NCI’s Sharpless to Head FDA; Care Planning; Patient Safety; More
White House Releases FY 2020 Budget – Earlier this week, the White House released the President’s Budget. This year's budget proposes to repeal and replace the Affordable Care Act (ACA) and cap Medicaid, and cuts federal health spending by $659 billion over 10 years. The budget also proposes shaving $818 billion from projected spending on Medicare over 10 years and cutting nearly $1.5 trillion from projected spending on Medicaid. [...]
What Caught Our Eye: Poor Doctor-Patient Communication; Senate GOP & Medicaid Cuts; Using Cancer “Battle Words;” News from ASCO17
What Caught Our Eye (WCOE) is our week-in-review blog series. June 9, 2017 | In the Spotlight: Via USA Today — For patients near the end of life, talking about their goals and values can help people avoid unwanted medical interventions, said Dr. Rachelle Bernacki, associate director of the Serious Illness Care Program at Ariadne Labs, a health care research center led by Dr. Atul Gawande. [...]
What Caught Our Eye: Next Steps for the ACA; Gottlieb’s Confirmation; ASCO Statement on Right-to-Try; Gene Mutations in Childhood Survivors
Some key findings of the most recent Kaiser tracking poll: the public thinks it’s a “good thing” that the AHCA failed, believes President Trump and the Republican party are responsible for problems with the ACA going forward, and want to see the Trump administration make the ACA work for consumers. “Despite divided views towards the 2010 health law, three-fourths of the public think President Trump and his administration [...]
What Caught Our Eye: A Cancer Survivor’s Comic, ACA Repeal Back on GOP Agenda, New Susan Gubar Piece, Past NCI Chief on Trump’s NIH Cuts
Andy Slavitt, former acting director of CMS, argues that the failure of Trumpcare last week presents the opportunity to end the divisiveness that hampered the Obamacare era and move forward in a bipartisan direction that focuses not on destructive rhetoric, but squarely on reducing premiums and expanding access for all Americans. [...]
Ask Your Oncologist About Clinical Drug Trials
If you had asked me in December 2012 if I would ever participate in a clinical drug trial, my answer would have been a resounding, “No.” The very word “trial” scared me off; I didn’t want to be a guinea pig, a test subject. I wanted proven medicine.
Share Your ACA Story
We at NCCS are carefully monitoring the transition to the Trump administration and what it means for cancer survivors, patients, and families. We need YOUR help to identify stories of cancer survivors who have benefited from the ACA, so we can share these with policymakers and protect the important provisions of the ACA that help cancer survivors.